CSE PREV
LAST 0.30
CHANGE 0.01
OTC PRVCF
FSE 18H
CSE: PREV
LAST: 0.30
CHANGE: 0.01
OTC: PRVCF
FSE: 18H

PreveCeutical (Australia) Pty Ltd.

PreveCeutical (Australia) Pty Ltd.

PreveCeutical has established a wholly owned subsidiary in Brisbane, Queensland, Australia to bolster their research and development interests. The Australian team which will be led by Dr. Maher Khaled, the Chief Executive Officer will work closely with Dr. Harry Parekh, PreveCeutical’s Chief Research Officer, to advance the company’s therapeutic pipeline. The office will provide access for regular engagement with commercial partners on other ventures that PreveCeutical is pursuing in the region.

 

Stephen Van Deventer

Chairman, Director

Mr. Van Deventer is an experienced business person and corporate director. Specialising in international corporate relations and business development over the last twenty-five years, Mr. Van Deventer has focused on launching small to medium-sized companies into the public markets in Canada, the United States and Europe. He has also owned and operated private businesses.

Maher Khaled PhD, LLB, BSc

Chief Executive Officer, Corp Secretary, Director

Dr. Khaled has spent over a decade commercializing therapeutic and diagnostic technologies developed at the University of Queensland and the University of Cambridge, UK. Whilst at Cambridge Enterprise Seed Funds, he held directorships with three companies, two of which were after investing in their seed round and both went on to raise further venture capital investment and sell products. He has a Doctorate of Biotechnology as well as a LLB and a BSc, all from the University of Queensland. He is an admitted solicitor of the Supreme Court of Queensland and has an Investment Management Certificate (UK).

Kimberly Van Deventer

Director

Kimberly Van Deventer is an entrepreneur with a successful track record of accomplishment that she brings to PreveCeutical. Motivated and determined, she was ranked the third highest grossing female business owner in BC, Canada in 2009. Kim is a driving force behind the business and is unwavering in her commitment to bringing awareness of health and disease prevention to people everywhere.

Shabira Rajan MBA, CPA, CGA

Chief Financial Officer

Ms. Rajan is a senior financial executive with over 20 years of experience, leading the financial discipline for successful businesses in both private and public sectors. She has a track record of providing leadership for strategic value creation and continuous improvement, as well as, providing effective direction to organisations on issues relating to corporate governance, financial oversight and risk management. One of her leadership roles was that of Director of Finance at Canada Line Rapid Transit Inc., which planned and constructed a $2 billion rapid transit system in metro-Vancouver, on time and within budget.

Sign up for the latest news and updates